نتائج البحث - Jörger, Markus
- يعرض 1 - 3 نتائج من 3
-
1
Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland حسب Begré, Ursina B. M., Jörger, Markus, Aebi, Stefan, Amstutz, Ursula, Largiadèr, Carlo R.
منشور في 2022نص -
2
Characteristics and survival of patients with cancer with intended off-label use—a cohort study حسب Schmitt, Andreas Michael, Walter, Martin, Herbrand, Amanda Katherina, Jörger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars, Kasenda, Benjamin
منشور في 2022نص -
3
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival حسب Berner, Fiamma, Niederer, Rebekka, Luimstra, Jolien J., Pop, Oltin Tiberiu, Jochum, Ann-Kristin, Purde, Mette-Triin, Hasan Ali, Omar, Bomze, David, Bauer, Jens, Freudenmann, Lena Katharina, Marcu, Ana, Wolfschmitt, Eva-Maria, Haen, Sebastian, Gross, Thorben, Dubbelaar, Marissa Lisa, Abdou, Marie-Therese, Baumgaertner, Petra, Appenzeller, Christina, Cicin-Sain, Caroline, Lenz, Tobias, Speiser, Daniel E., Ludewig, Burkhard, Driessen, Christoph, Jörger, Markus, Früh, Martin, Jochum, Wolfram, Cozzio, Antonio, Rammensee, Hans-Georg, Walz, Juliane, Neefjes, Jacques, Flatz, Lukas
منشور في 2021نص